Your browser doesn't support javascript.
loading
Development of VU6036864: A Triazolopyridine-Based High-Quality Antagonist Tool Compound of the M5 Muscarinic Acetylcholine Receptor.
Li, Jinming; Orsi, Douglas L; Engers, Julie L; Long, Madeline F; Capstick, Rory A; Maurer, Mallory A; Presley, Christopher C; Vinson, Paige N; Rodriguez, Alice L; Han, Allie; Cho, Hyekyung P; Chang, Sichen; Jackson, Megan; Bubser, Michael; Blobaum, Anna L; Boutaud, Olivier; Nader, Michael A; Niswender, Colleen M; Conn, P Jeffrey; Jones, Carrie K; Lindsley, Craig W; Han, Changho.
Afiliación
  • Li J; Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, Tennessee 37232, United States.
  • Orsi DL; Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States.
  • Engers JL; Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, Tennessee 37232, United States.
  • Long MF; Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States.
  • Capstick RA; Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, Tennessee 37232, United States.
  • Maurer MA; Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States.
  • Presley CC; Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, Tennessee 37232, United States.
  • Vinson PN; Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States.
  • Rodriguez AL; Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, Tennessee 37232, United States.
  • Han A; Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States.
  • Cho HP; Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, Tennessee 37232, United States.
  • Chang S; Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States.
  • Jackson M; Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, Tennessee 37232, United States.
  • Bubser M; Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States.
  • Blobaum AL; Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, Tennessee 37232, United States.
  • Boutaud O; Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States.
  • Nader MA; Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, Tennessee 37232, United States.
  • Niswender CM; Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States.
  • Conn PJ; Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, Tennessee 37232, United States.
  • Jones CK; Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States.
  • Lindsley CW; Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, Tennessee 37232, United States.
  • Han C; Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, United States.
J Med Chem ; 67(16): 14394-14413, 2024 Aug 22.
Article en En | MEDLINE | ID: mdl-39105778
ABSTRACT
While the muscarinic acetylcholine receptor mAChR subtype 5 (M5) has been studied over decades, recent findings suggest that more in-depth research is required to elucidate a thorough understanding of its physiological function related to neurological and psychiatric disorders. Our efforts to identify potent, selective, and pharmaceutically favorable next-generation M5 antagonist tool compounds have led to the discovery of a novel triazolopyridine-based series. In particular, VU6036864 (45) showed exquisite potency (human M5 IC50 = 20 nM), good subtype selectivity (>500 fold selectivity against human M1-4), desirable brain exposure (Kp = 0.68, Kp,uu = 0.65), and high oral bioavailability (%F > 100%). VU6036864 (45) and its close analogues will support further studies of M5 as advanced antagonist tool compounds and play an important role in the emerging biology of M5.
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Piridinas / Receptor Muscarínico M5 Límite: Animals / Humans Idioma: En Revista: J Med Chem Asunto de la revista: QUIMICA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Piridinas / Receptor Muscarínico M5 Límite: Animals / Humans Idioma: En Revista: J Med Chem Asunto de la revista: QUIMICA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos